Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants.
Panda added that India has taken a smart vaccination approach.
“Covaxin presents to the immune system a wide array of antigens,” said Panda.
He added, “The array of proteins and range of cells are the soldiers of immunity which will be developed following vaccination.
So that will be able to address the mutants as well.
I’m not tremendously worried and we don’t have any scientific evidence as yet that the mutants are going to challenge the efficacy of the vaccine.” Panda added, “Within 10-12 months, the vaccine has come out and this underlines the superiority, ability and the commitment of the scientists of India and I would say this is phenomenal.” Watch the full video for more.
